Natriuretic peptides: the feline experience

Area of Science:

• Veterinary Cardiology
• Biomarker Research
• Feline Medicine

Background:

• Natriuretic peptides (NP), especially NT-proBNP, show significant potential as biomarkers in feline medicine.
• The availability of commercial ELISAs has spurred research into NP for diagnosing feline cardiovascular disease.

Purpose of the Study:

• To review and synthesize current research on the utility of natriuretic peptides in diagnosing feline cardiovascular disease.
• To contextualize study findings within clinical practice, addressing areas of agreement, controversy, and confounding factors.

Main Methods:

• Literature review of studies examining natriuretic peptides (NP) in feline cardiovascular disease.
• Analysis of research findings, focusing on diagnostic utility, prognostic value, and treatment guidance.

Main Results:

• Research indicates NP are valuable aids in diagnosing feline heart conditions.
• Interpretation of NP concentrations is influenced by various confounding factors, leading to some controversy.
• Areas of agreement and disagreement in current literature are explored.

Conclusions:

• Natriuretic peptides show considerable potential for feline cardiovascular disease diagnosis and prognosis.
• Further research is essential to fully establish the clinical utility of NP in guiding feline treatment.
• Understanding confounding factors is crucial for accurate NP interpretation in clinical practice.